BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 28970297)

  • 1. Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre.
    Majumdar K; Sakhuja P; Puri AS; Gaur K; Haider A; Gondal R
    J Clin Pathol; 2018 May; 71(5):412-419. PubMed ID: 28970297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
    Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
    Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
    Lo Iacono O; Petta S; Venezia G; Di Marco V; Tarantino G; Barbaria F; Mineo C; De Lisi S; Almasio PL; Craxì A
    Am J Gastroenterol; 2005 Nov; 100(11):2472-7. PubMed ID: 16279902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.
    Moreno ML; Cebolla Á; Muñoz-Suano A; Carrillo-Carrion C; Comino I; Pizarro Á; León F; Rodríguez-Herrera A; Sousa C
    Gut; 2017 Feb; 66(2):250-257. PubMed ID: 26608460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
    Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
    Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
    Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
    Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Celiac Disease: Taking a Bite Out of the Controversy.
    Turner JM
    Dig Dis Sci; 2018 Jun; 63(6):1384-1391. PubMed ID: 29616378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac Dietary Adherence Test and Standardized Dietician Evaluation in Assessment of Adherence to a Gluten-Free Diet in Patients with Celiac Disease.
    Gładyś K; Dardzińska J; Guzek M; Adrych K; Małgorzewicz S
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques.
    Dutta R; Iqbal A; Das P; Palanichamy JK; Singh A; Mehtab W; Chauhan A; Aggarwal A; Sreenivas V; Ahuja V; Datta Gupta S; Makharia GK
    J Clin Pathol; 2021 Dec; 74(12):766-773. PubMed ID: 33789921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
    Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease.
    Johnston SD; McMillan SA; Collins JS; Tham TC; McDougall NI; Murphy P
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1001-4. PubMed ID: 12923373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
    Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
    World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care.
    Aziz I; Lewis NR; Hadjivassiliou M; Winfield SN; Rugg N; Kelsall A; Newrick L; Sanders DS
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):33-9. PubMed ID: 24216570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
    Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.
    Kurppa K; Paavola A; Collin P; Sievänen H; Laurila K; Huhtala H; Saavalainen P; Mäki M; Kaukinen K
    Gastroenterology; 2014 Sep; 147(3):610-617.e1. PubMed ID: 24837306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization Time of Celiac Serology in Children on a Gluten-free Diet.
    Gidrewicz D; Trevenen CL; Lyon M; Butzner JD
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):362-367. PubMed ID: 28231071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oats to children with newly diagnosed coeliac disease: a randomised double blind study.
    Högberg L; Laurin P; Fälth-Magnusson K; Grant C; Grodzinsky E; Jansson G; Ascher H; Browaldh L; Hammersjö JA; Lindberg E; Myrdal U; Stenhammar L
    Gut; 2004 May; 53(5):649-54. PubMed ID: 15082581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.
    Leffler D; Schuppan D; Pallav K; Najarian R; Goldsmith JD; Hansen J; Kabbani T; Dennis M; Kelly CP
    Gut; 2013 Jul; 62(7):996-1004. PubMed ID: 22619366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.